Novartis Korea was nominated as a full member nation for ICRO

Novartis head office has nominated Novartis Korea as a full member unit for the ICRO (International Clinical Research Operations) of Novartis and decided to expand R&D investment for clinical research works of anti-cancer drugs.

The nomination implied a recognition of Novarti Korea as an affiliate company with full capabilities of clinical studies at an international level. Thus, Novartis Ko...